Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.

Autor:	Steele RJ; Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.; Scottish Bowel Screening Centre, NHS Tayside, Kings Cross Hospital, Dundee, UK., Carey FA; Department of Pathology, Ninewells Hospital and Medical School, Dundee, UK., Stanners G; Quality Indicators, NHS National Services Scotland, Glasgow, UK., Lang J; Quality Indicators, NHS National Services Scotland, Glasgow, UK., Brand J; National Specialist and Screening Services Directorate, Edinburgh, UK., Brownlee LA; Scottish Bowel Screening Centre, NHS Tayside, Kings Cross Hospital, Dundee, UK., Crichton EM; Public Health Directorate, NHS Greater Glasgow and Clyde, Glasgow, UK., Winter JW; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Phull PS; Department of Digestive Disorders, Aberdeen Royal Infirmary, Aberdeen, UK., Mowat C; Department of Gastroenterology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK., Strachan JA; Department of Blood Sciences and Scottish Bowel Screening Laboratory, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK., Digan AM; Scottish Bowel Screening Centre, NHS Tayside, Kings Cross Hospital, Dundee, UK., Fraser CG; Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Jazyk:	angličtina
Zdroj:	Journal of medical screening [J Med Screen] 2020 Jun; Vol. 27 (2), pp. 59-67. Date of Electronic Publication: 2019 Nov 05.
DOI:	10.1177/0969141319879955
Abstrakt:	Objectives: Flexible sigmoidoscopy screening at around age 60 can reduce colorectal cancer incidence. Insufficient evidence exists on flexible sigmoidoscopy at age 60 in a population being offered biennial faecal occult blood test screening from age 50. This randomized controlled trial assessed if flexible sigmoidoscopy would be an effective adjunct to faecal occult blood test. Methods: In the Scottish Bowel Screening Programme between June 2014 and December 2015, 51,769 individuals were randomized to be offered flexible sigmoidoscopy instead of faecal occult blood test at age 60 or to continue faecal occult blood test. Those not accepting flexible sigmoidoscopy and those with normal flexible sigmoidoscopy were offered faecal occult blood test. All with flexible sigmoidoscopy-detected neoplasia or a positive faecal occult blood test result were offered colonoscopy. Results: Overall flexible sigmoidoscopy uptake was 17.8%, higher in men than women, and decreased with increasing deprivation (25.7% in the least to 9.2% in the most deprived quintile). In those who underwent flexible sigmoidoscopy, detection rate for colorectal cancer was 0.13%, for adenoma 7.27%, and for total neoplasia 7.40%. In those who underwent colonoscopy after a positive flexible sigmoidoscopy, detection rate for colorectal cancer was 0.28%, adenoma 8.66%, and total neoplasia 8.83%. On an intention to screen basis, there was no difference in colorectal cancer detection rate between the study and control groups. Adenoma and total neoplasia detection rate were significantly higher in the study group, with odds ratios of 5.95 (95%CI: 4.69-7.56) and 5.10 (95%CI: 4.09-6.35), respectively. Conclusions: In a single screening round at age 60, there was low uptake and neoplasia detection rate. Flexible sigmoidoscopy detected significantly more neoplasia than faecal occult blood test alone.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu